Insider Shareholders with Direct Ownership of Janux Therapeutics, Inc. (JANX)
This section provides a comprehensive overview of the insiders with direct ownership of Janux Therapeutics, Inc. (JANX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Janux Therapeutics, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Bregua Corp
> 10% Shareholder |
3,749,250 | 0 | 3,749,250 $165 Million | 1 |
Jun 15, 2021
Added 1.54%
|
David Alan Campbell
President and CEO |
81,000 | 120,000 | 293,054 $12.9 Million | 7 |
Jan 07, 2025
Reduced 1.68%
|
Thomas Di Raimondo
Chief Scientific Officer |
24,000 | 5,000 | 129,719 $5.72 Million | 2 |
Jan 02, 2025
Added 15.61%
|
10,097 | 0 | 115,139 $5.08 Million | 3 |
Nov 05, 2024
Added 3.85%
|
|
Andrew Hollman Meyer
Chief Business Officer |
77,881 | 63,334 | 82,139 $3.62 Million | 5 |
Jan 02, 2025
Reduced 0.24%
|
Charles M. Winter
Chief Technical Officer |
23,000 | 0 | 77,288 $3.41 Million | 1 |
Jan 02, 2025
Added 22.93%
|
6,298 | 0 | 70,348 $3.1 Million | 3 |
Nov 05, 2024
Added 3.17%
|
|
Byron Robinson
Chief Strategy Officer |
28,000 | 0 | 28,000 $1.24 Million | 1 |
Jan 02, 2025
Added 50.0%
|
Zachariah Mc Iver
Chief Medical Officer |
26,000 | 0 | 26,000 $1.15 Million | 1 |
Jan 02, 2025
Added 50.0%
|
Maria Dobek
Vice President, Accounting |
14,000 | 0 | 14,001 $617,584 | 1 |
Jan 02, 2025
Added 50.0%
|
7,500 | 0 | 7,500 $330,825 | 1 |
Jul 19, 2024
Added 25.0%
|
|
7,500 | 0 | 7,500 $330,825 | 1 |
Jul 19, 2024
Added 25.0%
|
|
6,315 | 3,815 | 7,000 $308,770 | 3 |
Sep 13, 2024
Reduced 35.28%
|
|
4,212,121 | 2,333,184 | 6,887 $303,785 | 18 |
Sep 30, 2024
Reduced 12.21%
|
|
2,500 | 0 | 2,500 $110,275 | 1 |
Jun 26, 2024
Added 50.0%
|
|
2,500 | 0 | 2,500 $110,275 | 1 |
Jun 26, 2024
Added 50.0%
|
|
2,500 | 0 | 2,500 $110,275 | 1 |
Jun 26, 2024
Added 50.0%
|
|
2,500 | 0 | 2,500 $110,275 | 1 |
Jun 26, 2024
Added 50.0%
|